Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0029463 (osteosarcoma)
 16,637 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Thirty-five cases of primary malignant fibrous histiocytoma of bone are reported. Twenty of these cases were collected from a retrospective analysis of other malignant bone tumors. The age range was from 11 to 69 years; the average age was 34 years. The tumor occurred most commonly in the distal femur and proximal tibia. The distinguishing histologic feature was a storiform arrangement of spindle cells. The differential diagnosis included fibrosarcoma, osteogenic sarcoma, malignant giant cell tumor, malignant lymphoma, and metastatic carcinoma. Follow-up of at least three years was available in 21 cases. Of these, nine patients were alive and free of metastases three and one-half to 12 years after treatment. Two were alive with solitary metastases at three years, and 10 patients died between three months and three years after treatment. In four cases the lesions were multicentric at the time of diagnosis and in four cases were associated with bone infarction. This tumor must be recognized as an important complication of bone infarction and should be suspected when a patient with a known history of bone infarction develops a change in symptoms. Because the prognosis of this tumor is significantly better than that in those tumors with which it had been previously grouped, and in view of its association with bone infarction, it deserves to be maintained as a distinct clinicopathologic entity. Amputation is the treatment of choice.
 ...
PMID:Malignant fibrous histiocytoma of bone: a study of 35 cases. 21 83

Malignant fibrous histiocytomas are well-described tumors of the soft tissues. Recent investigations have shown that malignant histiocytoma may also occur as a primary bone tumor. However, difficulties may arise to distinguish malignant histiocytoma of bone from other malignant bone tumors, such as osteosarcoma. In the present study, the ultrastructure of five cases of malignant fibrous histiocytoma of bone is compared with that of osteosarcoma. The results show that malignant fibrous histiocytoma is composed mainly of histiocytic cells and fibroblastic cells. In addition, xanthomatous cells, undifferentiated cells, and giant cells may be observed. By contrast, the predominant cell type in osteosarcoma is the neoplastic osteoblast, characterized by abundant rough endoplasmic reticulum. Signs of matrix calcification in the intercellular matrix between the collagen fibrils are regularly observed in osteosarcoma, but not in malignant histiocytoma. From these results it is concluded that the ultrastructure of malignant fibrous histiocytoma arising in bone is morphologically identical with the soft tissue counterpart of this tumor. The components of the tumor are derived from neoplastic histiocytes. This cytogenesis differs from that of osteosarcoma, which is derived from neoplastic osteoblasts. Therefore, from the ultrastructural point of view, malignant fibrous histiocytoma of bone should be accepted as a distinct histologic entity among bone tumors.
 ...
PMID:Malignant fibrous histiocytoma of bone and osteosarcoma. A comparative light and electron microscopic study. 22 75

The effect of preoperative adjuvant treatment on encapsulation around the tumors was studied histologically in 16 patients with osteosarcoma and 2 patients with malignant fibrous histiocytoma of bone. The reactive zone in biopsy specimens was transformed into collagenous connective tissue after preoperative adjuvant treatment. The whole sections of specimens resected surgically from all 18 patients showed a thick capsule formation at the peri- and parosteal region of the tumors. However, no capsular structure was identified in the bone marrow. In skeletal muscles, the degree of encapsulation was correlated with the effect of preoperative adjuvant treatment. These results suggest that effective preoperative adjuvant treatment on malignant bone tumors clarifies the border between the tumors and the normal tissues in the extraosseous part, especially in the peri- and parosteal region.
 ...
PMID:Encapsulation around malignant bone tumors after preoperative adjuvant treatment. 131 68

A series of 205 pediatric patients affected by osteosarcoma, Ewing's sarcoma, fibrosarcoma, and malignant fibrous histiocytoma of bone were treated from 1978 to 1988. Ninety-eight percent of the patients received chemotherapy and 63% had a surgical resection. Sixty-five percent of all patients were alive at 30 months and were considered disease free. The functional results after surgery were evaluated according to the Musculoskeletal Tumor Society score. In all diaphyseal resections and resections of the upper extremity and pelvis, the results were excellent or good in 60% of the cases. In resections of the proximal femur, distal femur, or proximal tibia and reconstruction with nonexpansible prostheses, the results were excellent or good in 75%. On the other hand, when arthrodeses of the lower extremity were used, only 14% of cases had a good result. This correlates with the resulting lack of articulation and serious limb shortening seen with progression of skeletal growth.
 ...
PMID:The management of malignant bone tumors in children and adolescents. 199 30

Between March 1983 and September 1988, 22 patients with non-metastatic malignant fibrous histiocytoma MFH of bone of the extremities were treated with two regimens of neo-adjuvant chemotherapy successively activated. Preoperatively, the patients received moderate doses of methotrexate and cisplatinum-Regimen 1- or high dose methotrexate, cisplatinum and adriamycin-Regimen 2. Cisplatinum was delivered intraarteriously, the other drugs intravenously. Limb salvage surgery was performed in 20 patients, and 2 patients were amputated. The surgical margins were adequate (radical or wide) in 18 cases and inadequate (marginal) in 4. The histologic response to chemotherapy was good (90% or more tumor necrosis) in 8 patients. In both regimens postoperative chemotherapy was tailored according to the grade of necrosis determined by preoperative treatment on the primary tumor. At an average follow-up of 40 months (15-70), 15 patients (68%) remained continuously disease-free and 7 relapsed with metastases. No local recurrences were observed. Regimen 2 was slightly more effective than Regimen 1 in terms of good histologic response (5/10 vs 1/12) and continuous disease-free survival (8/10 vs 7/127). The results demonstrate that, as in osteosarcoma, in non-metastatic malignant fibrous histiocytoma of bone in the extremities a high percentage of patients can be cured with neoadjuvant chemotherapy and that in most of them limb sparing surgery is possible and safe.
 ...
PMID:Primary chemotherapy and delayed surgery for malignant fibrous histiocytoma of bone in the extremity. 217 84

Since 1927, 130 patients with well-documented malignant fibrous histiocytoma of bone have been diagnosed and treated at Memorial Hospital for Cancer and Allied Diseases. This sarcoma is 10 times less frequent than osteogenic sarcoma in this hospital. It most commonly occurred spontaneously (72%), whereas in the rest (28%) it followed previous radiation or various pre-existent osseous conditions, most often Paget's disease. The appendicular skeleton was the commonest site of involvement. The majority of the patients were middle-aged or older adults with a mean of 40.5 years of age; only 21.5% were 21 years or younger. Histologically, the lesions were subclassified as fibrous (62%), histiocytic or xanthomatous (30%), and malignant giant cell tumor (8%) variants. Older patients were more likely to have a secondary malignant fibrous histiocytoma, especially following radiation or Paget's disease. Overall survival estimates at 2 years and 5 years were 71% and 53%, respectively. Survival was not dependent on the histologic subtype of the lesion, but was strongly influenced by the histologic grade of malignancy. Important prognostic factors were the age of the patients and whether the lesions were primary de novo or secondary sarcomas: the older patients and those with secondary lesions did substantially worse.
 ...
PMID:The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients. 300 Feb 4

In treating malignant bone tumors of the limbs, what might be accepted as a reasonable therapy is preserving the functions of the affected limb, with controlling tumor both locally and systemically. Concerning giant cell tumor of bone (low malignancy), malignant fibrous histiocytoma of bone and primary or secondary chondrosarcoma (moderate malignancy) and osteosarcoma (high malignancy), surgical treatments to preserve the affected limb and to maintain it's function are going to be introduced with their actual applications mainly through clinical cases. In the treatment for osteosarcoma of the child, even after succeed in preserving the affected limb, there are some problems of the development of the limb, disorders of the local skin and soft tissue, and troubles concerning artificial materials.
 ...
PMID:[Functional treatment of malignant bone tumors]. 608 71

Our present knowledge about bone tumors is still in need of a convincing cytohistogenetic concept that would support the adequate differentiation and classification of different tumor types. The modern therapeutic approach must rely on subtle diagnostis using preferably cyto- and histomorphologic criteria. The present study depends on a considerable number of malignant and semimalignant bone tumors which were analysed by several modern investigative methods. Based on these results, we intend to find the answers to some problems of cytogenesis and histogenesis of bone tumors. Comparison and correlation of our findings with the results of other authors is attempted with the objective to propose an overall histogenetic concept of bone tumors in consideration of the known data and hypotheses. Our material comprises 85 malignant and semimalignant bone tumors. The following tumor types are discussed on the basis of cases from our collection (numbers in brackets): "Conventional" highly malignant osteosarcoma (32), parosteal and periosteal osteosarcoma (2), telangiectatic osteosarcoma (2), small cell osteosarcoma (1), small cell sclerosing osteosarcoma (2), histiocytic osteosarcoma (1), Ewing's sarcoma (15), "conventional" chondrosarcoma (7), dedifferentiated chondrosarcoma (2), mesenchymal chondrosarcoma (1), giant cell tumor (12), malignant fibrous histiocytoma of bone (5), fibrosarcoma of bone (3), The results of conventional light and electron microscopy, but also of enzyme histochemistry and autoradiography were included in the definitive classification by both histologic and cytologic criteria. In addition, different collagen types present in the ground substance of these tumors were studied by immunofluorescence microscopy; in anaplastic tumors of high malignancy the intermediate filaments of the cytoskeleton were further subjected to immunohistochemical analysis. The concept resulting from these studies may be briefly summarized as follows: The stem cell of conventional, highly malignant osteosarcoma is a stromal cell of the skeletal system, which is undergoing neoplastic transformation. At first this cell fails to show any sign of collagen synthesis, the activity of alkaline phosphatase is not increased. Of a primarily anaplastic nature, this tumor cell may differentiate in several directions: in osteoblastic differentiation, the cell will produce predominantly collagen type I, and alkaline phosphatase activity will increase. During fibroblastic differentiation we observe an increased synthesis of collagen type III, but alkaline phosphatase activity is not raised.(ABSTRACT TRUNCATED AT 400 WORDS)
 ...
PMID:[Cytogenesis and histogenesis of malignant and semimalignant bone tumors]. 609 60

Malignant fibrous histiocytoma of bone is a histologically well-defined tumor. Our aim is to describe five own cases and to analyze the published cases in order to demonstrate, the controversial aspects of clinical pathology. The essential histological criteria are the storiform tissue pattern and the presence of fibroblastic and histiocytic cells and giant cells. Inclusive of our cases, the total number reported stands at 196. There are features of malignant fibrous histiocytoma of bone about which there is almost general agreement: 1. The tumor occurs at all ages with an average onset from the age of 10 to the age of 50. 2. The tumor occurs in both the long and flat bones, but the main sites are the distal femur and the proximal tibia. 3. The tumor lacks any initial distinctive features in its clinical phase, but with respect to its biological behaviour, malignant fibrous histiocytoma of bone can be distinguished from osteosarcoma.
 ...
PMID:[Malignant fibrous histiocytoma of bone. Clinical pathology and histological diagnosis]. 631 98

Twenty-seven osteosarcomas of bone were examined by electron microscopy. Eighteen cases were conventional osteosarcomas, one case was an osteosarcoma that developed in Paget's disease of bone, two cases were metastasis to the lungs of conventional osteosarcomas, five were parosteal osteosarcomas (and the recurrence of one of them), and one was periosteal osteosarcoma. In addition to the basic neoplastic cell, the osteoblast-like tumor cell, seven tumor cell types could be differentiated in varying numbers in the 27 cases examined: (1) chondroblast-like; (2) fibroblast-like; (3) histiocyte-like; (4) myofibroblast; (5) osteoclast-like; (6) malignant multinucleated osteoblast-like; and (7) atypical primitive mesenchymal cells. Moreover, endothelial cells and pericytes were also present. The tumor cells showed common neoplastic features in relation with general cell configuration and fine structures. No cytoplasmic organelle was considered to be cell-specific, and only the amount and distribution of the organelles allowed us to differentiate the above mentioned cell types. The presence of malignant appearing tumor cells with abundant and dilated cisternae of RER, in an intercellular matrix containing collagen fibers with areas of focal collections or puffs of hydroxyapatite crystals, are the most characteristic ultrastructural features of osteosarcoma. However, those features are not pathognomonic and do not allow in all cases the differential diagnosis with osteoid-osteoma and benign osteoblastoma. Fields of chondroblastic, fibroblastic, or fibrohitiocytic character are indistinguishable of chondrosarcomas, fibrosarcomas, or malignant fibrous histiocytoma of bone, respectively. The comparative study of parosteal and conventional osteosarcomas revealed a marked difference in the cell population: fibroblast-like cells and myofibroblasts were the main cell types in parosteal osteosarcoma; on the contrary, myofibroblasts were very scarce or absent in conventional osteosarcomas. This difference may correlate with the better outcome of parosteal osteosarcoma. The ultrastructural features of a periosteal osteosarcoma are reported for the first time. The tumor was comprised mostly of chondroblast-like tumor cells. However, in the more cellular peripheric areas of the neoplasm, the cells were predominantly of the fibroblast-like type and showed anaplastic features.
 ...
PMID:The ultrastructure of conventional, parosteal, and periosteal osteosarcomas. 695 92


1 2 3 Next >>